NCT07022678View on ClinicalTrials.gov

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

556

Participants

Timeline

Start Date

January 20, 2026

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2032

Conditions
Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Interventions
OTHER

Best Practice

Given standard chemotherapy

PROCEDURE

Biospecimen Collection

Undergo saliva sample collection

DRUG

Cytarabine

Given IV

OTHER

Electronic Health Record Review

Ancillary studies

DRUG

Placebo Administration

Given intraorally

OTHER

Xylitol-containing Oral Wipe

Given intraorally

All Listed Sponsors
lead

Children's Oncology Group

NETWORK